Board Members

José Carlos Gutiérrez-Ramos

Independent Director

Dr. José Carlos Gutiérrez-Ramos is a reputed Immunologist. He got his PhD in 1987 at the Center for Molecular Biology - Universidad Complutense de Madrid (Spain). He continued his postdoctoral research first at the Max-Plank Institute für Immunbiologie in Freiburg (Germany) and later as Scientist and Member at the Basel Institute for Immunology of F. Hoffmann-LaRoche in Basel (Switzerland). He is Full Professor (on leave) at the Spanish Scientific Research Council (CSIC) of the National Center for Biotechnology (CNB) in Madrid (Spain). From 1991-97 he was Assistant Professor (tenure track) at the Department of Genetics and Investigator at the Center for Blood Research from Harvard Medical School in Boston (Ma, USA). From 2012 to 2014 he was Lecturer at MIT Sloan School of Management at the MIT Center for Entrepreneurship in Cambridge (Ma, USA).

From his ample experience in the biopharmaceutical industry it is worth noting that in the period 2010-2015, he was Group Senior Vice President WorldWide R&D and Global Head of Biotherapeutics R&D at Pfizer and Head of its Research Center in Cambridge/Boston. Previously from 2007 to 2009 he was Senior Vice President and Director of the Group of Immunoinflammation and Discovery of Drugs (iiCEDD) of GSK, where he founded the Epinova Epigenetics Unit. Previously, he held responsibility functions in Amgen, Peptimmune and Millenium Pharmaceuticals. In his current role as President and CEO of Synlogic (SYBX, NASDAQ) since 2015, he has raised more than two hundred (200) million dollars with the participation of specialized investment funds such as Orbimed, Deerfield, Sofinova, NEA, Atlas, EcoR1, Millenium, Farallon, Perceptive, and RockSprings, among others.